A Phase 2a Crossover Trial Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2019
Price : $35 *
At a glance
- Drugs Dapivirine (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 26 Jul 2019 Planned End Date changed from 30 Jun 2021 to 30 Nov 2021.
- 26 Jul 2019 Planned primary completion date changed from 30 Jun 2021 to 30 Nov 2021.
- 25 Feb 2019 Planned End Date changed from 1 Jun 2021 to 30 Jun 2021.